Trade KZIA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kazia Therapeutics Limited American Depositary Shares (KZIA) is trading at US$11.19, up 1.63% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$153.18M. Over the past 52 weeks, KZIA has traded between US$4.86 and US$17.40. On Syfe you can trade KZIA with $0 commission and add it to your watchlist.
| Previous close | US$11.01 |
|---|---|
| Market cap | US$153.18M |
| 52-week range | US$4.86 – US$17.40 |
| Volume | 340.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kazia Therapeutics Limited American Depositary Shares
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Year: 1999
Stay on top of KZIA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
